The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Mutations Affecting G-Protein Subunit α11in Hypercalcemia and Hypocalcemia
Open accessAbstract
BACKGROUND: Familial hypocalciuric hypercalcemia is a genetically heterogeneous disorder with three variants: types 1, 2, and 3. Type 1 is due to loss-of-function mutations of the calcium-sensing receptor, a guanine nucleotide-binding protein (G-protein)-coupled receptor that signals through the G-protein subunit α11 (Gα11). Type 3 is associated with adaptor-related protein complex 2, sigma 1 subunit (AP2S1) mutations, which result in altered calcium-sensing receptor endocytosis. We hypothesized that type 2 is due to mutations effecting Gα11 loss of function, since Gα11 is involved in calcium-sensing receptor signaling, and its gene (GNA11) and the type 2 locus are colocalized on chromosome 19p13.3. We also postulated that mutations effecting Gα11 gain of function, like the mutations effecting calcium-sensing receptor gain of function that cause autosomal dominant hypocalcemia type 1, may lead to hypocalcemia. METHODS: We performed GNA11 mutational analysis in a kindred with familial hypocalciuric hypercalcemia type 2 and in nine unrelated patients with familial hypocalciuric hypercalcemia who did not have mutations in the gene encoding the calcium-sensing receptor (CASR) or AP2S1. We also performed this analysis in eight unrelated patients with hypocalcemia who did not have CASR mutations. In addition, we studied the effects of GNA11 mutations on Gα11 protein structure and calcium-sensing receptor signaling in human embryonic kidney 293 (HEK293) cells. RESULTS: The kindred with familial hypocalciuric hypercalcemia type 2 had an in-frame deletion of a conserved Gα11 isoleucine (Ile200del), and one of the nine unrelated patients with familial hypocalciuric hypercalcemia had a missense GNA11 mutation (Leu135Gln). Missense GNA11 mutations (Arg181Gln and Phe341Leu) were detected in two unrelated patients with hypocalcemia; they were therefore identified as having autosomal dominant hypocalcemia type 2. All four GNA11 mutations predicted disrupted protein structures, and assessment on the basis of in vitro expression showed that familial hypocalciuric hypercalcemia type 2-associated mutations decreased the sensitivity of cells expressing calcium-sensing receptors to changes in extracellular calcium concentrations, whereas autosomal dominant hypocalcemia type 2-associated mutations increased cell sensitivity. CONCLUSIONS: Gα11 mutants with loss of function cause familial hypocalciuric hypercalcemia type 2, and Gα11 mutants with gain of function cause a clinical disorder designated as autosomal dominant hypocalcemia type 2. (Funded by the United Kingdom Medical Research Council and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Mutations in GNA11 in Uveal Melanoma
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,476
Heterotrimeric G protein activation by G-protein-coupled receptors
Oldham, W. M., & Hamm, H. E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2299 · Cited by 1,184
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Pollak, M. R., Brown, E. M., Chou, Y.-H. W., Hebert, S. C., Marx, S. J., Stelnmann, B., Levi, T., Seidman, C. E., & Seidman, J. G. (1993) · Cell · doi:10.1016/0092-8674(93)90617-y · Cited by 1,043
Pearce, S. H. S., Williamson, C., Kifor, O., Bai, M., Coulthard, M. G., Davies, M., Lewis-Barned, N., McCredie, D., Powell, H., Kendall-Taylor, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351505 · Cited by 629
Self-citationExtracellular calcium sensing and signalling
Hofer, A. M., & Brown, E. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1154 · Cited by 612
The ras protein family: evolutionary tree and role of conserved amino acids
Valencia, A., Chardin, P., Wittinghofer, A., & Sander, C. (1991) · Biochemistry · doi:10.1021/bi00233a001 · Cited by 573
Snapshot of Activated G Proteins at the Membrane: The Gα q -GRK2-Gßγ Complex
Tesmer, V. M., Kawano, T., Shankaranarayanan, A., Kozasa, T., & Tesmer, J. J. G. (2005) · Science · doi:10.1126/science.1118890 · Cited by 289
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
Nesbit, M. A., Hannan, F. M., Howles, S. A., Reed, A. A. C., Cranston, T., Thakker, C. E., Gregory, L., Rimmer, A. J., Rust, N., Graham, U., et al. (2013) · Nature Genetics · doi:10.1038/ng.2492 · Cited by 282
Self-citationStructural basis for the specific inhibition of heterotrimeric G q protein by a small molecule
Nishimura, A., Kitano, K., Takasaki, J., Taniguchi, M., Mizuno, N., Tago, K., Hakoshima, T., & Itoh, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003553107 · Cited by 252
Synthesis in Escherichia coli of GTPase-deficient mutants of Gsα
Graziano, M. P., & Gilman, A. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84854-8 · Cited by 251
Inherited Diseases Involving G Proteins and G Protein–Coupled Receptors
Spiegel, A. M., & Weinstein, L. S. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103843 · Cited by 249
Kimple, A. J., Bosch, D. E., Giguère, P. M., & Siderovski, D. P. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003038 · Cited by 230
Kinetic Scaffolding Mediated by a Phospholipase C–β and G q Signaling Complex
Waldo, G. L., Ricks, T. K., Hicks, S. N., Cheever, M. L., Kawano, T., Tsuboi, K., Wang, X., Montell, C., Kozasa, T., Sondek, J., et al. (2010) · Science · doi:10.1126/science.1193438 · Cited by 218
Bramucci, E., Paiardini, A., Bossa, F., & Pascarella, S. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s4-s2 · Cited by 204
Hannan, F. M., Nesbit, M. A., Zhang, C., Cranston, T., Curley, A. J., Harding, B., Fratter, C., Rust, N., Christie, P. T., Turner, J. J. O., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds105 · Cited by 192
Self-citationEffects of G-protein mutations on skin color
Van Raamsdonk, C. D., Fitch, K. R., Fuchs, H., de Angelis, M. H., & Barsh, G. S. (2004) · Nature Genetics · doi:10.1038/ng1412 · Cited by 183
Mutations in the chromatin-associated protein ATRX
Gibbons, R. J., Wada, T., Fisher, C. A., Malik, N., Mitson, M. J., Steensma, D. P., Fryer, A., Goudie, D. R., Krantz, I. D., & Traeger-Synodinos, J. (2008) · Human Mutation · doi:10.1002/humu.20734 · Cited by 180
Wettschureck, N., Lee, E., Libutti, S. K., Offermanns, S., Robey, P. G., & Spiegel, A. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0110 · Cited by 122
Biochemical and Functional Characterization of Germ Line KRAS Mutations
Schubbert, S., Bollag, G. E., Lyubynska, N., Nguyen, H. T., Kratz, C. P., Zenker, M., Niemeyer, C. M., Molven, A., & Shannon, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00965-07 · Cited by 103
Yamamoto, M., Akatsu, T., Nagase, T., & Ogata, E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7035 · Cited by 87
The arginine finger strikes again
Bourne, H. R. (1997) · Nature · doi:10.1038/39470 · Cited by 80
Reed, A. J., Loh, N. Y., Terryn, S., Lippiat, J. D., Partridge, C., Galvanovskis, J., Williams, S. E., Jouret, F., Wu, F., Courtoy, P. J., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00038.2009 · Cited by 72
Self-citationRapid Activation of Transducin by Mutations Distant from the Nucleotide-binding Site
Marin, E. P., Krishna, A. G., & Sakmar, T. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100198200 · Cited by 64
Cited by
Walker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Feng, X., Degese, M. S., Iglesias-Bartolome, R., Vaque, J. P., Molinolo, A. A., Rodrigues, M., Zaidi, M. R., Ksander, B. R., Merlino, G., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 563
Khan, A. A., Hanley, D. A., Rizzoli, R., Bollerslev, J., Young, J. E. M., Rejnmark, L., Thakker, R., D’Amour, P., Paul, T., Van Uum, S., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3716-2 · Cited by 544
Self-citationThe calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L., & Thakker, R. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0115-0 · Cited by 394
Self-citationPresentation of Hypoparathyroidism: Etiologies and Clinical Features
Shoback, D. M., Bilezikian, J. P., Costa, A. G., Dempster, D., Dralle, H., Khan, A. A., Peacock, M., Raffaelli, M., Silva, B. C., Thakker, R. V., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3909 · Cited by 371
Self-citation
Metadata
- Authors
- Nesbit, M. A., Hannan, F. M., Howles, S. A., Babinsky, V. N., Head, R. A., Cranston, T., Rust, N., Hobbs, M. R., Heath, H., & Thakker, R. V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-06-27
- Volume
- 368
- Issue
- 26
- Pages
- 2476-2486
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1986685849
- Cited by
- 405
- References
- 27
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.